CRVO

1.4609.77%
JS

Joshua S. Boger

Independent Chair of the Board

Dr. Joshua S. Boger, Ph.D., has been Chairman of Alkeus Pharmaceuticals, Inc. since July 2024 and served as its Executive Chairman until July 2024. He serves as an Independent Chair of the Board at CervoMed Inc. since February 2024. He served as Executive Chairman of Vertex Pharmaceuticals Incorporated from 1997 to May 2006 and also its Chief Executive Officer from 1992 to May 23, 2009. Dr. Boger is an industry veteran who has served in multiple scientific and business leadership roles in his 40 year career. Dr. Boger is an innovative scientist and highly successful business executive who has extensive drug development and biopharmaceutical company leadership experience. Dr. Boger served as the President of Vertex Pharmaceuticals Incorporated from May 11, 2005 to February 2009 and from 1989 to December 2000 and as its Chief Scientific Officer from 1989 to May 1992. He founded Vertex Pharmaceuticals Incorporated in 1989. He began his industry career at Merck in 1978. He serves as a Director at Large of Biotechnology Industry Organization. Dr. Boger has been a Director of ActivBiotics, Inc. since December 2005 and Massachusetts Life Sciences Center since August 2011. Dr. Boger served as Chairman of Healthcare of Biotechnology Industry Organization. He serves as a Director of The Hastings Center, Inc. He served as a Director at Vertex Pharmaceuticals Incorporated since 1989 until June 8, 2017. He served as a Director of Metaphore Pharmaceuticals Inc. He served as Senior Director of Basic Chemistry of Merck Sharp & Dohme Research Laboratories in Rahway, New Jersey, where he headed both the Department of Medicinal Chemistry of Immunology & Inflammation and the Department of Biophysical Chemistry. During his 10 years at Merck, Dr. Boger developed an international reputation in the application of computer modeling to the chemistry of drug design and pioneered the use of structure-based rational drug design as the basis for drug discovery programs. He has authored over 50 scientific publications and holds 32 issued U.S. patents in pharmaceutical discovery and development. His postdoctoral research in molecular recognition was performed in the laboratories of the Nobel-prize winning chemist, Jean-Marie Lehn, in Strasbourg, France. He holds a B.A. in Chemistry and Philosophy from Wesleyan University and M.S. and Ph.D. degrees in Chemistry from Harvard University.

Positions